Seabrook Partner, Cepheid at Front Line of Covid19 Battle

Seabrook Partner, Cepheid at Front Line of Covid19 Battle

From medicaldevice-network.com: Cepheid has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its rapid molecular diagnostic test, Xpert Xpress SARS-CoV-2. The test is designed for the qualitative detection of SARS-CoV-2...

New Look for Seabrook Technology Group!

As you can see, there are many changes taking place at Seabrook Technology Group. Our look is evolving to better represent who we are as Manufacturing Technology Experts, and we have expanded our team to serve our partners and prospects with great care and expertise....